ATS 2018 International Conference - Mobile

Safety and Efficacy of Oral RV521 in a Human Respiratory Syncytial Virus (RSV) Phase 2a Challenge Study

Location: 32A

Session Type: Late Breaking Mini Symposium

Monday

May

21

11:00 AM

11:15 AM

Speaker(s)/Author(s)

Dereck Tait

MD
ReViral Ltd

Eddy Littler

PhD
ReViral Ltd

Olufeyikemi Oluwayi

MD
hVivo

Rachel Harland

PhD
ReViral Ltd

John DeVincenzo

MD
University of Tennessee

Elaine Thomas

PhD
ReViral Ltd

Julie Mori

PhD
hVivo

Ken Powell

PhD
ReViral Ltd

Stuart Cockerill

PhD
ReViral Ltd

Neil Mathews

PhD
ReViral Ltd

View Abstract

Safety and Efficacy of Oral RV521 in a Human Respiratory Syncytial Virus (RSV) Phase 2a Challenge Study

Parent Sessions

B14 - LATE BREAKING CLINICAL TRIALS AND FIRST REPORTS IN ASTHMA AND COPD...
05-21-2018 9:15 AM - 11:15 AM